Journal Information
Vol. 17. Issue 4.
Pages 497-499 (July - August 2013)
Share
Share
Download PDF
More article options
Vol. 17. Issue 4.
Pages 497-499 (July - August 2013)
Letter to the Editor
Open Access
Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study
Visits
3809
Mohammad Taghi Haghi Ashtiania, Setareh Mamishib, Ahmad Masoomia, Nafiseh Nasiria, Mohammad Hosseinia, Bahram Nikmanesha, Babak Pourakbarib, Nima Rezaeic,d,e,
Corresponding author
rezaei_nima@tums.ac.ir

Corresponding author at: Children's Medical Center Hospital, 62 Qarib St, Keshavarz Blvd, Tehran 14194, Iran.
a Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
b Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
c Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
d Molecular Immunology Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
e Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Antimicrobial susceptibility profile of isolated bacteria.
Full Text
Dear Editor,

Bacterial pathogens are becoming more and more resistant to antibiotics used commonly by healthcare practitioners. Despite introduction of new antibiotics, empiric treatment of patients with bloodstream infections (BSIs) became a major challenge for practicing physicians.1,2

To depict the susceptibility patterns of BSI pathogens endemic in a referral pediatric hospital, Children's Medical Center (Tehran, Iran), the antimicrobial susceptibility patterns among 3593 patients were reviewed in a 5-year period (2006–2010). Bacterial identification and disk diffusion susceptibility testing were performed, using standard methods.3

Percentages of Gram positive and Gram negative bacteria were 35% (1265/3593) and 65% (2328/3593), respectively. Enterobacter spp. (25.9%), Pseudomonas aeroginosa (25.5%), and Coagulase-negative staphylococci (CoNS) (23.2%) were the most frequent agents, followed by Staphylococcus aureus (6.2%) and Klebsiella spp. (5.9%), collectively accounting for 87% of all BSI blood isolates cultured. were Staphylococcus spp., followed by Viridans group streptococci, Streptococcus pneumonia, and Entrococcus spp. comprised about 84% of all Gram positive bacteria isolated from blood cultures. Among Gram negative bacteria, Enterbacter spp., Pseudomonas aeruginosa, Klebsiella spp., E. coli, and Salmonella spp. accounted for about 95% of isolates. Table 1 shows the antimicrobial susceptibility pattern of Gram positive and Gram negative bacteria in this study. CoNS are almost always resistant to oxacillin. Furthermore, the rate of susceptibility is very low among S. aureus (13.2%) and S. pneumoniae (7%). Vancomycin showed an acceptable antibiotic effect on CoNS, S. aureus, S. pneumoniae and viridans group Streptococci, with susceptibility rates of 93.2%, 95.3%, 96.4% and 92.7%, respectively. Among staphylococcal isolates S. aureus was more susceptible to clindamycin (82.9% versus 52.9%) and to trimethoprim/sulfamethoxazole (60.9% versus 34.0%) than CoNS. S. pneumoniae was highly susceptible to ceftriaxone (93.9%), cefalotin (96.6%), and vancomycin (96.4%). About half of the Klebsiella spp. isolates tested were resistant to amikacin. The rate of resistance to ampicillin, ceftriaxone and piperacillin-tazobactam was as high as 97.7%, 66.7% and 35.4%, respectively. The rate of E. coli resistance to amikacin was similar to that of Klebsiella spp. On the contrary, Imipenem showed to be quite effective in both organisms (Table 1).

Table 1.

Antimicrobial susceptibility profile of isolated bacteria.

Bacteria  Antimicrobial  Total no.  Percent susceptible 
Gram positive bacteria
Viridans group streptococci  Ceftriaxone  71.6  67 
  Clindamycin  67  77.6 
  Chloramphenicol  40  82.5 
  Erythromycin  65  52.3 
  Penicillin  37  40.5 
  Vancomycin  110  92.7 
Enterococcus spp.  Chloramphenicol  13  69.2 
  Erythromycin  17  11.8 
  Gentamicin  28  25 
  Penicillin  12  8.3 
  Vancomycin  29  62.1 
Gram negative bacteria
Klebsiella spp.  Amikacin  148  48.0 
  Ampicillin  133  2.3 
  Ceftriaxone  129  33.3 
  Cefalotin  153  11.8 
  Chloramphenicol  82  52.4 
  Trimethoprim/sulfamethoxazole  178  57.3 
  Gentamicin  206  44.2 
  Imipenem  76  97.3 
  Cefepime  141  73.0 
  Ceftazidime  121  67.8 
Escherichia coli  Amikacin  71  53.0 
  Ampicillin  63  12.7 
  Ceftriaxone  64  50.0 
  Cefalotin  87  33.3 
  Chloramphenicol  43  79.1 
  Trimethoprim/sulfamethoxazole  100  27.0 
  Gentamicin  108  61.1 
  Imipenem  33  97.0 
  Tobramycin  66.7  36.0 
  Piperacillin-Tazobactam  91  70.3 
Pseudomonas aeruginosa  Amikacin  617  39.4 
  Ceftazidime  558  16.3 
  Ceftriaxone  547  7.9 
  Chloramphenicol  456  30.2 
  Ciprofloxacin  481  94.6 
  Gentamycin  904  41.6 
  Kanamycin  473  4.6 
  Imipenem  91  68.1 
  Tobramycin  329  30.7 
Enterobacter spp.  Amikacin  715  93.4 
  Ampicillin  708  4.1 
  Ceftriaxone  679  92.3 
  Chloramphenicol  695  85.5 
  Ciprofloxacin  693  99.4 
  Trimethoprim/sulfamethoxazole  847  92.9 
  Gentamicin  867  93.5 
  Kanamycin  577  76.1 
  Imipenem  23  87.0 
  Tobramycin  507  94.1 
  Piperacillin-Tazobactam  343  73.8 
Salmonella spp.  Amikacin  24  100 
  Ampicillin  21  71.4 
  Cefalotin  24  87.5 
  Chloramphenicol  10  90.0 
  Trimethoprim/sulfamethoxazole  31  83.9 
  Kanamycin  88.8 
  Gentamicin  36  94.4 
  Imipenem  100 
  Tobramycin  10  100 
  Piperacillin-Tazobactam  31  71.0 
Acinetobacter spp.  Amikacin  12  58.3 
  Chloramphenicol  50.0 
  Kanamycin  28.6 
  Gentamicin  18  66.7 
  Tobramycin  33.3 
Haemophilus spp.  Amikacin  12  66.7 
  Ceftriaxone  10  80.0 
  Chloramphenicol  71.4 
  Trimethoprim/sulfamethoxazole  19  36.8 
  Kanamycin  33.3 
  Gentamicin  20  65.0 
  Imipenem  100 
  Penicillin  100 
  Tobramycin  83.3 

Although bacteriologic culture is the keystone of management of septicemia, culture result takes time; therefore, understanding the regional bacterial susceptibility and pattern of resistance to antimicrobial agents is very important to prepare treatment guidelines. In two previous studies conducted in the same hospital during 1995–2000 and 2001–2005, the prevalence of Gram positive bacteria was reported as 72.0% and 47.6%, respectively.4,5 However, the recent data showed that the Gram negative microorganisms have become much more prevalent. These data also show that the pattern of antimicrobial resistance in Iran is different from other parts of the world. Thus, based on the observed changes therapeutic regimens prescribed by health practitioners in Iran should be modified.

Conflict of interest

The authors declare no conflict of interest.

References
[1]
D.M. Shlaes, D.N. Gerding, J.F. John Jr., et al.
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.
Clin Infect Dis, 25 (1997), pp. 584-599
[2]
M.A. Pfaller, R.N. Jones, G.V. Doern, K. Kugler.
Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).
Antimicrob Agents Chemother, 42 (1998), pp. 1762-1770
[3]
M.A. Wikler.
Performance standards for antimicrobial disk susceptibility tests: approved standard.
Clinical and Laboratory Standards Institute, (2006),
[4]
S. Mamishi, B. Pourakbari, M.H. Ashtiani, F.B. Hashemi.
Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996–2000.
Int J Antimicrob Agents, 26 (2005), pp. 373-379
[5]
B. Pourakbari, A. Sadr, M.T. Ashtiani, et al.
Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran.
J Infect Dev Countries, 6 (2012), pp. 120-125
Copyright © 2013. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools